Skip to main content

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q2 2023
Holdings of MLTX by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−117,000−100.0%Sold outHolders
Q3 2023117,000$6.67M0.2%00.0%UnchangedHolders
Q2 2023117,000$5.97M0.1%+117,000NewHolders